Can we introduce evidence based prescribing of complementary drug therapies into primary care? A randomised controlled trial.

Completed

• Conditions: Gonarthrosis; Musculoskeletal Diseases; Osteoarthritis

• Registration Number: ISRCTN19338940
• Lead Sponsor: Bury Primary Care Trust (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-12-20
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 55

Inclusion Criteria

General practitioners in Bury PCT

Exclusion Criteria

General practitioners on the local medicines management subgroup and the other GPs in their practices

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in the mean number of prescriptions for glucosamine sulphate 500 mg per general practitioner over study period.

Secondary Outcome Measures

Name	Time	Method
1. Change in cost to the NHS of prescriptions for glucosamine per general practitioner over study period<br>2. Proportion of GP prescribing glucosamine sulphate 500 mg during study period<br>3. If sufficient change in prescribing observed, number of admissions for gastrointestinal bleeding<br>4. Change in mean number of prescriptions of NSAID and COX2